Literature DB >> 32926297

Heat shock protein B8 promotes proliferation and migration in lung adenocarcinoma A549 cells by maintaining mitochondrial function.

Ling-Ling Yu1,2, Yuan Wang3, Zu-Ke Xiao2, Sheng-Song Chen4,5,6.   

Abstract

Heat shock protein B8 (HSPB8) impacts on tumor proliferation and migration of malignancy. However, the role of HSPB8 in lung adenocarcinoma (LUAC) remains unclear. The aim of this study, therefore, was to clarify whether HSPB8 could bring benefits to proliferation and migration of LUAC and its underlying mechanisms. The expression of HSPB8 was first evaluated by immunohistochemistry in 35 LUAC samples. Then, A549 lung adenocarcinoma cells were transfected with pcDNA-HSPB8 or si-HSPB8 to induce HSPB8 overexpression and silence. Cellular activity was evaluated with a Cell Counting Kit-8 (CCK-8) assay. Cell proliferation and migration were observed by EdU assay and scratch assay. Mitochondria-specific reactive oxygen species (mtROS) and membrane potential were measured using MitoSOX Red probe and JC-1 staining. Superoxide dismutase (SOD) activities and malondialdehyde (MDA) level were measured using commercial kits, respectively. HSPB8 protein, mitochondrial fusion protein MFN2 and mitochondrial fission protein p-Drp1/Drp1 were measured using western blot. Compared with the normal tissues, the expression of HSPB8 protein was higher in LUAC tissues and upregulation of HSPB8 protein was related to tumor size and tumor location. Furthermore, HSPB8 overexpression aggravated cell proliferation and migration of A549 cells. Mechanistically, HSPB8 suppressed mitochondrial impairment, leading to promoting the progress of A549 lung adenocarcinoma cells. These data demonstrate that HSPB8 plays an important role in progression of LUAC and may be a new target to treat LUAC.

Entities:  

Keywords:  A549 cells; Heat shock protein B8; Lung adenocarcinoma; Migration; Mitochondrial function; Proliferation

Mesh:

Substances:

Year:  2020        PMID: 32926297     DOI: 10.1007/s11010-020-03896-3

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  41 in total

1.  Anticancer activities of chalcone flavokawain B from Alpinia pricei Hayata in human lung adenocarcinoma (A549) cells via induction of reactive oxygen species-mediated apoptotic and autophagic cell death.

Authors:  You-Cheng Hseu; Yu-Chi Huang; Varadharajan Thiyagarajan; Dony Chacko Mathew; Kai-Yuan Lin; Ssu-Ching Chen; Jer-Yuh Liu; Li-Sung Hsu; Mei-Ling Li; Hsin-Ling Yang
Journal:  J Cell Physiol       Date:  2019-03-07       Impact factor: 6.384

2.  Mitochondrial oxidative stress causes mitochondrial fragmentation via differential modulation of mitochondrial fission-fusion proteins.

Authors:  Shengnan Wu; Feifan Zhou; Zhenzhen Zhang; Da Xing
Journal:  FEBS J       Date:  2011-02-03       Impact factor: 5.542

3.  LATS2 promotes apoptosis in non-small cell lung cancer A549 cells via triggering Mff-dependent mitochondrial fission and activating the JNK signaling pathway.

Authors:  Yudong Xie; Yanping Lv; Yanli Zhang; Zhenzhen Liang; Lili Han; Yiyang Xie
Journal:  Biomed Pharmacother       Date:  2018-11-05       Impact factor: 6.529

4.  Peptide nucleic acids targeting mitochondria enhances sensitivity of lung cancer cells to chemotherapy.

Authors:  Sheng-Song Chen; Xiao-Yun Tu; Li-Xia Xie; Lv-Ping Xiong; Juan Song; Xiao-Qun Ye
Journal:  Am J Transl Res       Date:  2018-09-15       Impact factor: 4.060

5.  Mitofusin-2 over-expresses and leads to dysregulation of cell cycle and cell invasion in lung adenocarcinoma.

Authors:  Yuqing Lou; Rong Li; Jielin Liu; Yanwei Zhang; Xueyan Zhang; Bo Jin; Ya Liu; Zuoguang Wang; Hua Zhong; Shaojun Wen; Baohui Han
Journal:  Med Oncol       Date:  2015-03-22       Impact factor: 3.064

Review 6.  Targeting mitochondria metabolism for cancer therapy.

Authors:  Samuel E Weinberg; Navdeep S Chandel
Journal:  Nat Chem Biol       Date:  2015-01       Impact factor: 15.040

Review 7.  Mitochondrial dysfunction and oxidative stress in aging and cancer.

Authors:  Anna V Kudryavtseva; George S Krasnov; Alexey A Dmitriev; Boris Y Alekseev; Olga L Kardymon; Asiya F Sadritdinova; Maria S Fedorova; Anatoly V Pokrovsky; Nataliya V Melnikova; Andrey D Kaprin; Alexey A Moskalev; Anastasiya V Snezhkina
Journal:  Oncotarget       Date:  2016-07-19

8.  Phase I clinical trial of a novel autologous modified-DC vaccine in patients with resected NSCLC.

Authors:  Chunlei Ge; Ruilei Li; Haifeng Song; Tao Geng; Jinyan Yang; Qinghua Tan; Linfeng Song; Ying Wang; Yuanbo Xue; Zhen Li; Suwei Dong; Zhiwei Zhang; Na Zhang; Jiyin Guo; Lin Hua; Siyi Chen; Xin Song
Journal:  BMC Cancer       Date:  2017-12-21       Impact factor: 4.430

9.  Genome-wide analyses of long noncoding RNA expression profiles in lung adenocarcinoma.

Authors:  Zhenzi Peng; Jun Wang; Bin Shan; Fulai Yuan; Bin Li; Yeping Dong; Wei Peng; Wenwen Shi; Yuanda Cheng; Yang Gao; Chunfang Zhang; Chaojun Duan
Journal:  Sci Rep       Date:  2017-11-10       Impact factor: 4.379

10.  Ergosterol peroxide from marine fungus Phoma sp. induces ROS-dependent apoptosis and autophagy in human lung adenocarcinoma cells.

Authors:  Han-Ying Wu; Feng-Ling Yang; Lan-Hui Li; Yerra Koteswara Rao; Tz-Chuen Ju; Wei-Ting Wong; Chih-Yu Hsieh; Michael V Pivkin; Kuo-Feng Hua; Shih-Hsiung Wu
Journal:  Sci Rep       Date:  2018-12-18       Impact factor: 4.379

View more
  4 in total

1.  IL35 attenuated LPS-induced acute lung injury by regulating macrophage polarization.

Authors:  Shengsong Chen; Jingen Xia; Yi Zhang; Qingyuan Zhan
Journal:  Mol Biol Rep       Date:  2022-06-24       Impact factor: 2.742

Review 2.  The Role of HSPB8, a Component of the Chaperone-Assisted Selective Autophagy Machinery, in Cancer.

Authors:  Riccardo Cristofani; Margherita Piccolella; Valeria Crippa; Barbara Tedesco; Marina Montagnani Marelli; Angelo Poletti; Roberta M Moretti
Journal:  Cells       Date:  2021-02-05       Impact factor: 6.600

3.  Plasmatic Levels of HSP90α at Diagnosis: A Novel Prognostic Indicator of Clinical Outcome in Advanced Lung Cancer Patients Treated With PD-1/PD-L1 Inhibitors Plus Chemotherapy.

Authors:  Shubin Chen; Qitao Yu; Shaozhang Zhou
Journal:  Front Oncol       Date:  2021-12-03       Impact factor: 6.244

4.  HSPB8 is a Potential Prognostic Biomarker that Correlates With Immune Cell Infiltration in Bladder Cancer.

Authors:  Zhiyong Tan; Shi Fu; Yinglong Huang; Xianzhong Duan; Yigang Zuo; Xiaorui Zhu; Haifeng Wang; Jiansong Wang
Journal:  Front Genet       Date:  2022-03-07       Impact factor: 4.599

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.